Mandate

Vinge represented sellers when Polhem acquired shares in Solör

November 21, 2019

Vinge represented the sellers Meritor, Inc. Retirement Plan, Sunrise BE I, LLC and YRC Worldwide, Inc. Master Pension Plans Trust in their divestment of shares in Solör Bioenergi Holding AB (”Solör”) to Polhem Infra KB (”Polhem”).

Solör is a privately‑owned energy company with focus on sustainable district heating in Sweden and Norway. Polhem is an investment company wholly‑owned by the Swedish State Pension Funds AP1, AP3 and AP4. In the acquisition, which also involved BE Bio Energy Group AG on the sell‑side, Polhem acquired a total of 21.45 percent of the shares in Solör.

Vinges team comprised Johan Göthberg, Maria Dahlin Kolvik, Hanna Risberg and Agnes Widlund (trainee).

Related

Vinge has advised Course Corrected VC on the establishment of Course Corrected VC Fund II

Vinge has advised Course Corrected VC on the establishment and structuring of their second fund, Course Corrected VC Fund II (the “Fund”).
November 12, 2026

Vinge advises Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun

Vinge is advising Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun from Dalafast. The acquisition comprises four properties with a total of 23,200 square metres of retail space, which together constitute Tallen’s largest retail area.
November 11, 2026

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026